Ascl1 and OTP tumour expressions are associated with disease‐free survival in lung atypical carcinoids. Issue 6 (21st February 2023)
- Record Type:
- Journal Article
- Title:
- Ascl1 and OTP tumour expressions are associated with disease‐free survival in lung atypical carcinoids. Issue 6 (21st February 2023)
- Main Title:
- Ascl1 and OTP tumour expressions are associated with disease‐free survival in lung atypical carcinoids
- Authors:
- Centonze, Giovanni
Maisonneuve, Patrick
Simbolo, Michele
Lagano, Vincenzo
Grillo, Federica
Prinzi, Natalie
Pusceddu, Sara
Missiato, Loretta
Colantuono, Marilena
Sabella, Giovanna
Bercich, Luisa
Mangogna, Alessandro
Rolli, Luigi
Grisanti, Salvatore
Benvenuti, Mauro Roberto
Pastorino, Ugo
Roz, Luca
Scarpa, Aldo
Berruti, Alfredo
Capella, Carlo
Milione, Massimo - Abstract:
- Aims: According to World Health Organization guidelines, atypical carcinoids (ACs) are well‐differentiated lung neuroendocrine tumours with 2–10 mitoses/2 mm 2 and/or foci of necrosis (usually punctate). Besides morphological criteria, no further tools in predicting AC clinical outcomes are proposed. The aim of this work was to identify novel factors able to predict AC disease aggressiveness and progression. Methods and results: Three hundred‐seventy lung carcinoids were collected and centrally reviewed by two expert pathologists. Morphology and immunohistochemical markers (Ki‐67, TTF‐1, CD44, OTP, SSTR2A, Ascl1, p53, and Rb1) were studied and correlated with disease‐free survival (DFS) and overall survival (OS). Fifty‐eight of 370 tumours were defined as AC. Survival analysis showed that patients with Ascl1 + ACs and those with OTP‐ACs had a significantly worse DFS than patients with Ascl1‐ACs and OTP + ACs, respectively. Combining Ascl1 and OTP expressions, groups were formed reflecting the aggressiveness of disease ( P = 0.0005). Ki‐67 ≥10% patients had a significantly worse DFS than patients with Ki‐67 <10%. At multivariable analysis, Ascl1 (present versus absent, hazard ratio [HR] = 3.42, 95% confidence interval [CI] 1.35–8.65, P = 0.009) and OTP (present versus absent, HR = 0.26, 95% CI 0.10–0.68, P = 0.006) were independently associated with DFS. The prognosis of patients with Ki‐67 ≥10% tended to be worse compared to that with Ki‐67 <10%. On the contrary, OTPAims: According to World Health Organization guidelines, atypical carcinoids (ACs) are well‐differentiated lung neuroendocrine tumours with 2–10 mitoses/2 mm 2 and/or foci of necrosis (usually punctate). Besides morphological criteria, no further tools in predicting AC clinical outcomes are proposed. The aim of this work was to identify novel factors able to predict AC disease aggressiveness and progression. Methods and results: Three hundred‐seventy lung carcinoids were collected and centrally reviewed by two expert pathologists. Morphology and immunohistochemical markers (Ki‐67, TTF‐1, CD44, OTP, SSTR2A, Ascl1, p53, and Rb1) were studied and correlated with disease‐free survival (DFS) and overall survival (OS). Fifty‐eight of 370 tumours were defined as AC. Survival analysis showed that patients with Ascl1 + ACs and those with OTP‐ACs had a significantly worse DFS than patients with Ascl1‐ACs and OTP + ACs, respectively. Combining Ascl1 and OTP expressions, groups were formed reflecting the aggressiveness of disease ( P = 0.0005). Ki‐67 ≥10% patients had a significantly worse DFS than patients with Ki‐67 <10%. At multivariable analysis, Ascl1 (present versus absent, hazard ratio [HR] = 3.42, 95% confidence interval [CI] 1.35–8.65, P = 0.009) and OTP (present versus absent, HR = 0.26, 95% CI 0.10–0.68, P = 0.006) were independently associated with DFS. The prognosis of patients with Ki‐67 ≥10% tended to be worse compared to that with Ki‐67 <10%. On the contrary, OTP (present versus absent, HR = 0.28, 95% CI 0.09–0.89, P = 0.03), tumour stage (III‐IV versus I‐II, HR = 4.25, 95% CI 1.42–12.73, P = 0.01) and increasing age (10‐year increase, HR = 1.67, 95% CI 1.04–2.68, P = 0.03) were independently associated with OS. Conclusion: This retrospective analysis of lung ACs showed that Ascl1 and OTP could be the main prognostic drivers of postoperative recurrence. Abstract : Ascl1, OTP, and Ki‐67 drive the clinical outcome of lung atypical carcinoids. … (more)
- Is Part Of:
- Histopathology. Volume 82:Issue 6(2023)
- Journal:
- Histopathology
- Issue:
- Volume 82:Issue 6(2023)
- Issue Display:
- Volume 82, Issue 6 (2023)
- Year:
- 2023
- Volume:
- 82
- Issue:
- 6
- Issue Sort Value:
- 2023-0082-0006-0000
- Page Start:
- 870
- Page End:
- 884
- Publication Date:
- 2023-02-21
- Subjects:
- Ascl1 -- atypical carcinoids -- Ki‐67 index -- lung -- OTP
Histology, Pathological -- Periodicals
611.018 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=his ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2559 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/his.14873 ↗
- Languages:
- English
- ISSNs:
- 0309-0167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4316.027000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26920.xml